Table 7.
Correlation between circulating levels of CD34+, CD34 + KDR+, CD34 + CD133 + and CD34 + CD133 + KDR + cells and Female Sexual Function Index total score in the different phases of the menstrual cycle in women with diabetes and in healthy controls. Numbers in bold indicate statistical significant correlations
| Women with type 1 diabetes (N = 36) | ||||||
|---|---|---|---|---|---|---|
| FSFI total score | Follicular phase | Ovulatory phase | Luteal phase | |||
| rSp | P | rSp | P | rSp | P | |
| CD34+ | –0.483 | .003 | –0.075 | .660 | –0.367 | .028 |
| CD34 + KDR+ | –0.050 | .771 | 0.092 | .590 | –0.400 | .015 |
| CD34 + CD133+ | –0.056 | .732 | –0.703 | < .001 | 0.08 | .626 |
| CD34 + CD133 + KDR+ | –0.452 | .006 | –0.084 | .624 | –0.157 | .378 |
| Control women (N = 64) | ||||||
| CD34+ | 0.600 | < .001 | 0.702 | < .001 | 0.547 | < .001 |
| CD34 + KDR+ | 0.672 | < .001 | –0.034 | .791 | 0.738 | < .001 |
| CD34 + CD133+ | 0.596 | < .001 | –0.095 | .536 | 0.730 | < .001 |
| CD34 + CD133 + KDR+ | –0.214 | .742 | 0.750 | < .001 | 0.034 | .245 |
Abbreviation: FSFI, Female Sexual Function Index.